ArticleOncotarget2017

A c-Jun N-terminal kinase inhibitor, JNK-IN-8, sensitizes triple negative breast cancer cells to lapatinib.

Nancy D Ebelt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.